Novartis targets 5%+ annual sales growth through 2029 amid robust brand performance
Q4 2024 Management View CEO Vas Narasimhan highlighted Novartis' strong performance in Q4 2024, with sales increasing 16% and ...
Hosted on MSN47m
Novartis Gets Retail Chatting After Upbeat Q4, But Sentiment Stays Tepid Amid Volatile Trading
Shares of Swiss pharmaceutical giant Novartis AG were flat on Friday morning in heavy trading volume, despite the company reporting impressive quarterly results. Novartis posted core fourth-quarter ...
Healio27m
Treat dry eye before ocular surgery to avoid postoperative problems
Aggressive treatment before ocular surgery helps avoid postoperative issues with visual quality in patients with dry eye ...